UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 106

Sortiert nach

Mutational Status of the TP53 Gene As a Predictor of Response and Survival in Patients With Chronic Lymphocytic Leukemia: Results From the LRF CLL4 Trial

Journal of clinical oncology, 2011-06, Vol.29 (16), p.2223-2229

2011

Link zum Volltext

Verfügbarkeit prüfen

Rituximab, used alone or in combination, is superior to other treatment modalities in splenic marginal zone lymphoma

British journal of haematology, 2012-11, Vol.159 (3), p.322-328

2012

Link zum Volltext

Verfügbarkeit prüfen

The efficacy and tolerability of pomalidomide in relapsed/refractory myeloma patients in a "real-world" study: the Royal Marsden Hospital experience

Leukemia & lymphoma, 2017-02, Vol.58 (2), p.494-497

2017

Link zum Volltext

Verfügbarkeit prüfen

Long-term follow-up after purine analogue therapy in hairy cell leukaemia

Best practice & research. Clinical haematology, 2015-12, Vol.28 (4), p.217-229

2015

Link zum Volltext

Verfügbarkeit prüfen

Epidemiology and Environmental Aspects of Marginal Zone Lymphomas

Best practice & research. Clinical haematology, 2017-03, Vol.30 (1-2), p.84-91

2017

Link zum Volltext

Verfügbarkeit prüfen

Guidelines for the management of mature T‐cell and NK‐cell neoplasms (excluding cutaneous T‐cell lymphoma)

British journal of haematology, 2011-05, Vol.153 (4), p.451-485

2011

Link zum Volltext

Verfügbarkeit prüfen

Long-term results for pentostatin and cladribine treatment of hairy cell leukemia

Leukemia & lymphoma, 2011-06, Vol.52 (S2), p.21-24

2011

Link zum Volltext

Verfügbarkeit prüfen

Rituximab Plus Chlorambucil As First-Line Treatment for Chronic Lymphocytic Leukemia: Final Analysis of an Open-Label Phase II Study

Journal of clinical oncology, 2014-04, Vol.32 (12), p.1236-1241

2014

Link zum Volltext

Verfügbarkeit prüfen

Alemtuzumab therapy in T-cell prolymphocytic leukemia: comparing efficacy in a series treated intravenously and a study piloting the subcutaneous route

Blood, 2011-11, Vol.118 (22), p.5799-5802

2011

Link zum Volltext

Verfügbarkeit prüfen

Guideline for the treatment of chronic lymphocytic leukaemia: A British Society for Haematology Guideline

British journal of haematology, 2018-08, Vol.182 (3), p.344-359

2018

Link zum Volltext

Verfügbarkeit prüfen

Long‐term follow‐up of 233 patients with hairy cell leukaemia, treated initially with pentostatin or cladribine, at a median of 16 years from diagnosis

British journal of haematology, 2009-06, Vol.145 (6), p.733-740

2009

Link zum Volltext

Verfügbarkeit prüfen

Ocular and cerebral aspergillosis in a non-neutropenic patient following alemtuzumab and methyl prednisolone treatment for chronic lymphocytic leukaemia

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2010-04, Vol.16 (2), p.150-151

2010

Link zum Volltext

Verfügbarkeit prüfen

An unusual indication for splenectomy in hairy cell leukaemia: a report of three cases with persistent splenomegaly after chemoimmunotherapy

British journal of haematology, 2015-12, Vol.171 (5), p.784-787

2015

Link zum Volltext

Verfügbarkeit prüfen

Response to Imatinib Mesylate in Patients with Chronic Myeloproliferative Diseases with Rearrangements of the Platelet-Derived Growth Factor Receptor Beta

The New England journal of medicine, 2002-08, Vol.347 (7), p.481-487

2002

Link zum Volltext

Verfügbarkeit prüfen

Stem cell transplantation after alemtuzumab in T‐cell prolymphocytic leukaemia results in longer survival than after alemtuzumab alone: a multicentre retrospective study

British journal of haematology, 2010-06, Vol.149 (6), p.907-910

2010

Link zum Volltext

Verfügbarkeit prüfen

Guideline for the treatment of chronic lymphocytic leukaemia

British journal of haematology, 2018-08, Vol.182 (3), p.344-359

2018

Link zum Volltext

Verfügbarkeit prüfen

High remission rate in T-cell prolymphocytic leukemia with CAMPATH-1H

Blood, 2001-09, Vol.98 (6), p.1721-1726

2001

Link zum Volltext

Verfügbarkeit prüfen

Rituximab with pentostatin or cladribine: an effective combination treatment for hairy cell leukemia after disease recurrence

Leukemia & lymphoma, 2011-06, Vol.52 (S2), p.75-78

2011

Link zum Volltext

Verfügbarkeit prüfen

A comparison of the efficacy and safety of oral and intravenous fludarabine in chronic lymphocytic leukemia in the LRF CLL4 trial

Cancer, 2011-06, Vol.117 (11), p.2452-2460

2011

Link zum Volltext

Verfügbarkeit prüfen

High readmission rates are associated with a significant economic burden and poor outcome in patients with grade III/IV acute GvHD

Clinical transplantation, 2013-01, Vol.27 (1), p.E56-E63

2013

Link zum Volltext

Verfügbarkeit prüfen

T-cell prolymphocytic leukemia

Medical oncology (Northwood, London, England), 2006, Vol.23 (1), p.17-22

Dearden, Claire E

2006

Link zum Volltext

Verfügbarkeit prüfen

T-Cell Prolymphocytic Leukemia

Clinical lymphoma & myeloma, 2009-09, Vol.9, p.S239-S243

Dearden, Claire E.

2009

Link zum Volltext

Verfügbarkeit prüfen

Alemtuzumab in T-cell lymphoproliferative disorders

Best practice & research. Clinical haematology, 2006-01, Vol.19 (4), p.795-810

2006

Link zum Volltext

Verfügbarkeit prüfen

Alemtuzumab in the treatment of chronic lymphocytic lymphoma

Expert review of anticancer therapy, 2008-04, Vol.8 (4), p.525-533

2008

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 106

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(105)
Mit Volltextzugriff
(97)

Publikationsform

Artikel
(105)
Dissertationen
(1)

Sprache

Englisch
(106)
Japanisch
(6)

Erscheinungsjahr

n.n

Thema

Humans
(65)
Life Sciences & Biomedicine
(63)
Science & Technology
(63)
Hematology
(46)
Male
(37)
Aged
(34)
Female
(34)
Middle Aged
(34)
Adult
(29)
Biological And Medical Sciences
(29)
Medical Sciences
(29)
Hematologic And Hematopoietic Diseases
(26)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(25)
Oncology
(25)
Treatment Outcome
(24)
Antineoplastic Agents - Therapeutic Use
(21)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(19)
Aged, 80 And Over
(16)
Leukemia, Lymphocytic, Chronic, B-Cell - Drug Therapy
(16)
Prognosis
(16)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Mutational Status of the TP53 Gene As a Predictor of Response and Survival in Patients With Chronic Lymphocytic Leukemia: Results From the LRF CLL4 Trial

Alemtuzumab in Combination With Methylprednisolone Is a Highly Effective Induction Regimen for Patients With Chronic Lymphocytic Leukemia and Deletion of TP53: Final Results of the National Cancer Research Institute CLL206 Trial

Rituximab, used alone or in combination, is superior to other treatment modalities in splenic marginal zone lymphoma

The efficacy and tolerability of pomalidomide in relapsed/refractory myeloma patients in a "real-world" study: the Royal Marsden Hospital experience

Long-term follow-up after purine analogue therapy in hairy cell leukaemia

Epidemiology and Environmental Aspects of Marginal Zone Lymphomas

Guidelines for the management of mature T‐cell and NK‐cell neoplasms (excluding cutaneous T‐cell lymphoma)

Long-term results for pentostatin and cladribine treatment of hairy cell leukemia

Rituximab Plus Chlorambucil As First-Line Treatment for Chronic Lymphocytic Leukemia: Final Analysis of an Open-Label Phase II Study

Alemtuzumab therapy in T-cell prolymphocytic leukemia: comparing efficacy in a series treated intravenously and a study piloting the subcutaneous route

Guideline for the treatment of chronic lymphocytic leukaemia: A British Society for Haematology Guideline

Long‐term follow‐up of 233 patients with hairy cell leukaemia, treated initially with pentostatin or cladribine, at a median of 16 years from diagnosis

Ocular and cerebral aspergillosis in a non-neutropenic patient following alemtuzumab and methyl prednisolone treatment for chronic lymphocytic leukaemia

An unusual indication for splenectomy in hairy cell leukaemia: a report of three cases with persistent splenomegaly after chemoimmunotherapy

Response to Imatinib Mesylate in Patients with Chronic Myeloproliferative Diseases with Rearrangements of the Platelet-Derived Growth Factor Receptor Beta

Stem cell transplantation after alemtuzumab in T‐cell prolymphocytic leukaemia results in longer survival than after alemtuzumab alone: a multicentre retrospective study

Guideline for the treatment of chronic lymphocytic leukaemia

High remission rate in T-cell prolymphocytic leukemia with CAMPATH-1H

Rituximab with pentostatin or cladribine: an effective combination treatment for hairy cell leukemia after disease recurrence

A comparison of the efficacy and safety of oral and intravenous fludarabine in chronic lymphocytic leukemia in the LRF CLL4 trial

High readmission rates are associated with a significant economic burden and poor outcome in patients with grade III/IV acute GvHD

T-cell prolymphocytic leukemia

T-Cell Prolymphocytic Leukemia

Alemtuzumab in T-cell lymphoproliferative disorders

Alemtuzumab in the treatment of chronic lymphocytic lymphoma

Suchergebnisse filtern